alexa Editor - Robert J Deans | Regenerative Medicine | 1440
ISSN: 2161-1025

Translational Medicine
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
View More»
 

Robert J Deans

Robert J Deans Robert J Deans
Regenerative Medicine
Athersys Inc,
USA
 
Biography

Dr Deans is responsible for regenerative medicine technology development at Athersys Inc and its European subsidiary ReGenesys Athersys is developing cell therapeutics based on adherent stem cells. Multi Stemisolated from adult bone marrowAthersys has active Phase I and II clinical development activity in acute myocardial infarct stroke ulcerative colitis and for adjunctive therapy of allogeneic bone marrow transplant.  Dr Deans has more than 20years experience in stem cell therapeutics having previously served at Osiris. Therapeuticsas VP of Research Dr Deans was previously Director of RD at Baxter Healthcare where he developed biological components of the Isolex300i hematopoietic stem cell purification platformIn addition. Dr Deans served on the faculty at USC Medical School from 1984 to 1992 . He holds degrees from MIT and the University of Michigan and postdoctoral training in molecular immunology at UCLA.

Research Interest

Dr. Deans charge in the Immunotherapy Division was to develop a new biological reagent kit for the magnetic bead/monoclonal antibody capture of bone marrow and peripheral blood CD34+ hematopoietic stem cells. Using phage display technology, a small peptide mimetic of the epitope of an anti CD34 monoclonal antibody was derived and affinity matured through computationally directed mutagenesis for use as a competitive release reagent of the antibody/cell complex.

Certificate
Certificate

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

bornova escort

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]e.com

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version